Combined with Vectura acquisition from last year they will have a solid finger in each of the delivery method pies.
Would be interesting to get a manufacturing update for their prototype of IHL-216A delivery device. I still don't think the market has woken up to understand the significance of the USA push and the foresight of the BOD to use this exact NFL concussion model to reduce the cost and timeframe of progressing this trial. There will be a huge marketing buzz and publicity should these results mimic the earlier preclinical trials. https://www.reuters.com/business/philip-morris-seals-deal-buy-vectura-with-75-shares-tendered-2021-09-16/
IHL Price at posting:
40.0¢ Sentiment: Buy Disclosure: Held
